Insider · CIK 0001652479
Christopher A McGinnis
Files at GDRX (GoodRx Holdings, Inc.). First filing -, latest -.
In brief
Christopher A McGinnis files SEC Form 4 as officer at GDRX (GoodRx Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher A McGinnis has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +36,988 | - | - | 214,604 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -16,294 | $3.01 | $49k | 198,310 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -36,988 | $0.00 | $0 | 369,877 | Jul 16, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +44,779 | - | - | 197,342 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -19,726 | $2.49 | $49k | 177,616 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -44,779 | $0.00 | $0 | 492,580 | May 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | AGrant or award Class A Common Stock | +36,987 | - | - | 163,308 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -10,745 | $2.23 | $24k | 152,563 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -36,987 | $0.00 | $0 | 406,865 | Apr 15, 2026 |
| Mar 3, 2026 | GDRX GoodRx Holdings, Inc. | AGrant or award Restricted Stock Unitderivative | +443,852 | $0.00 | $0 | 443,852 | Mar 5, 2026 |
| Feb 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +179,120 | - | - | 179,120 | Feb 17, 2026 |
| Feb 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -52,799 | $2.18 | $115k | 126,321 | Feb 17, 2026 |
| Feb 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -179,120 | $0.00 | $0 | 537,359 | Feb 17, 2026 |
| Mar 3, 2025 | GDRX GoodRx Holdings, Inc. | AGrant or award Restricted Stock Unitderivative | +716,479 | $0.00 | $0 | 716,479 | Mar 5, 2025 |
| Mar 3, 2025 | GDRX GoodRx Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,096,937 | $0.00 | $0 | 1,096,937 | Mar 5, 2025 |
Questions about Christopher A McGinnis
Answered from the filings on this page, as of the latest one.
Is Christopher A McGinnis buying or selling?
Christopher A McGinnis has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher A McGinnis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher A McGinnis has 0.
Where does Christopher A McGinnis file Form 4?
Christopher A McGinnis has filed Form 4 at GDRX (GoodRx Holdings, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.